Women get HIV, the virus that causes AIDS, primarily through vaginal or anal sex with an infected partner. Sharing needles for drug injection is the other major route. While HIV can affect anyone, women face higher biological risk during sex than men do, largely because being the receptive partner during intercourse makes transmission more likely.
How HIV Spreads to Women
HIV lives in specific body fluids: blood, semen (including pre-ejaculate), vaginal fluids, rectal fluids, and breast milk. For a woman to contract HIV, one of these fluids from an infected person needs to enter her body through a mucous membrane, an open wound, or directly into the bloodstream.
The most common routes for women are:
- Vaginal sex: The estimated risk per act of receptive vaginal sex with an HIV-positive partner is about 8 in 10,000 exposures (0.08%). That sounds low, but repeated exposure over time adds up considerably.
- Anal sex: This carries the highest per-act risk of any sexual activity, at roughly 138 in 10,000 exposures (1.38%) for the receptive partner. The rectal lining is thinner than vaginal tissue, making it easier for the virus to enter.
- Sharing needles: Injecting drugs with shared equipment puts HIV-contaminated blood directly into the bloodstream. Among white women diagnosed with HIV in the United States, injection drug use accounts for 46% of cases.
- Oral sex: Transmission through oral sex is rare but not impossible, particularly if there are open sores or bleeding gums.
These per-act risk numbers only apply when the HIV-positive partner has a detectable viral load. Someone on effective treatment who maintains an undetectable viral load does not transmit the virus sexually.
Why Women Are More Vulnerable Than Men
Biology puts women at a disadvantage when it comes to HIV transmission during sex. Being the receptive partner, whether during vaginal or anal intercourse, is inherently riskier than being the insertive partner. Semen stays in contact with vaginal or rectal tissue for a longer period, giving the virus more opportunity to cross into the body.
The vaginal lining, while more resilient than rectal tissue, still has a large surface area of mucous membrane that HIV can penetrate. Older women face additional risk because age-related thinning and dryness of the vaginal walls can lead to small tears during sex, creating direct entry points for the virus. Any condition that causes inflammation or breaks in the skin of the genital area raises risk further.
Factors That Increase Your Risk
Having another sexually transmitted infection dramatically increases the chance of contracting HIV. STIs like herpes, syphilis, or gonorrhea can cause sores, inflammation, or tiny breaks in genital tissue that make it easier for HIV to enter the body. Even STIs that don’t cause visible sores trigger an immune response that draws the very cells HIV targets to the genital area.
Other factors that raise risk include having multiple sexual partners, not using condoms, and having sex with a partner whose HIV status you don’t know. In the U.S. in 2023, 19% of all new HIV diagnoses (about 7,350 cases) were among women. The burden is not evenly distributed: Black women accounted for half of all new diagnoses among women despite representing 13% of the female population, with a diagnosis rate 11 times higher than that of white women. These disparities reflect systemic differences in access to healthcare, prevention tools, and testing rather than any biological difference.
Mother-to-Child Transmission
A woman living with HIV can pass the virus to her baby during pregnancy, labor, delivery, or breastfeeding. Without any treatment, the transmission rate ranges from 15% to 45%. With proper antiretroviral treatment during pregnancy and delivery, that rate drops to around 2% or lower. This is one of the most successful prevention stories in HIV medicine, with countries like South Africa reducing vertical transmission to roughly 2% through widespread treatment programs.
Early Symptoms to Watch For
Within two to four weeks of infection, many people develop a flu-like illness that can last a few days to several weeks. Symptoms include fever, headache, muscle and joint pain, rash, sore throat, swollen lymph nodes (particularly in the neck), diarrhea, weight loss, and night sweats. These symptoms are easy to mistake for a regular cold or flu, which is why many women don’t realize they’ve been infected.
After this initial phase, HIV often enters a long period with no noticeable symptoms. Without testing, the infection can go undetected for years while the virus gradually weakens the immune system. AIDS is the late stage of HIV infection, when the immune system is severely damaged and the body becomes vulnerable to infections it would normally fight off easily.
Getting Tested
Modern HIV tests are highly accurate, but they can’t detect the virus immediately after exposure. A lab-based blood test drawn from a vein can typically detect HIV 18 to 45 days after exposure. A rapid finger-stick test has a wider window of 18 to 90 days. If you test too early, you may get a false negative, so timing matters. If you’ve had a potential exposure, testing at the right interval gives you a reliable result.
Prevention Options for Women
Condoms remain one of the most effective barriers against HIV when used consistently. But they aren’t the only tool available.
PrEP (pre-exposure prophylaxis) is a daily medication for people who don’t have HIV but are at ongoing risk. For vaginal sex, the pills reach maximum protection after about 21 days of daily use. Consistent adherence is critical: skipping doses can leave drug levels in the bloodstream too low to block the virus. Unlike for men who have sex with men, “on-demand” dosing (taking pills only around the time of sex) has not been proven effective for women.
If you think you’ve been exposed to HIV, post-exposure prophylaxis (PEP) is an emergency option. PEP must be started within 72 hours of exposure to be effective, and the sooner you begin, the better it works. After 72 hours, it is unlikely to prevent infection. PEP involves taking antiretroviral medication daily for 28 days.
Knowing your partner’s HIV status and viral load is another powerful form of protection. A person living with HIV who takes medication and maintains an undetectable viral load does not transmit the virus through sex, a principle known as “undetectable equals untransmittable.”